1. Medtech Insight
  2. >>Geography
  3. >>Europe

How The EU Needs To Address Conflicts Between AI And Medical Device Rules: Part 2

 
• By Amanda Maxwell

There are serious concerns about how the EU’s proposal for a new Artificial Intelligence Act could disrupt the regulation and supply of medical devices. Royal Philips’ Koen Cobbaert explained the issues in the second part of this two-part interview piece. Part 1 was published on 28 April.

Jirsak/Shutterstock.com
(Shutterstock)

In this second-part of a two-part interview piece, Koen Cobbaert, senior manager, quality, standards and regulations, at Royal Philips looks in more detail at the impossible situation that notified bodies could find themselves in due to the new AI Act, at how it will impact IVDs in particular, and at the very important, but potentially compromised, issue of standards.

Koen Cobbaert

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Small, Sleek, Ambitious: ViCentra Raises $85M To Develop Kaleido 2 Insulin Pump, Eyes US Market

 
• By Marion Webb

Dutch insulin pump maker ViCentra secured $85m to scale European manufacturing, preparing for the 2026 launch of its thinner, lighter Kaleido 2 pump and push into US market. CEO Tom Arnold said the pump has more than 3,500 users in Europe and expects “tens of thousands” in the next 18 months.

Salient Bio Raises £2.35M For March 2026 Rollout Of At-Home IBD Microbiome Test

 
• By Natasha Barrow

Salient's inflammatory bowel disease test, built on the start-up’s Signal platform, is planned to launch in March 2026. The company leverages rich data from existing wellness tests to develop signatures, focusing on conditions that are often misdiagnosed and disproportionately affect women.

Government-Backed UK Network Enhances Access To Clinical Trials

 
• By Vibha Sharma

The UK government expects that its new nation-wide network will enable companies to set up clinical trials more quickly and expand access to diverse patient populations across the National Health Service.

European Commission Review of the MDR and IVDR – Where Are We Right Now?

 
• By Amanda Maxwell

Political and regulatory pressures make revising the EU’s medtech regulations a tricky balancing act, two renowned medtech experts, Erik Vollebregt and Bassil Akra told Medtech Insight during a recent interview.

More from Geography

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 
• By Brian Bossetta

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.

Fairtility’s FDA-Cleared CHLOE Brings AI To Embryo Selection

 
• By Elizabeth Orr

Israeli device firm Fairtility recently obtained US FDA clearance for the CHLOE platform, which uses AI to make embryo assessments performed as part of in vitro fertilization more transparent, efficient and reliable.

Salient Bio Raises £2.35M For March 2026 Rollout Of At-Home IBD Microbiome Test

 
• By Natasha Barrow

Salient's inflammatory bowel disease test, built on the start-up’s Signal platform, is planned to launch in March 2026. The company leverages rich data from existing wellness tests to develop signatures, focusing on conditions that are often misdiagnosed and disproportionately affect women.